Sốc nhiễm trùng do Pasteurella multocida sau ghép gan được điều trị bằng drotrecogin alfa (kích hoạt)

Jones FL, 1973, Infections in man due to Pasteurella multocida, Pa Med, 76, 41

10.1097/00005792-198405000-00001

Carter GR., 1967, Pasteurellosis, Pasteurella multocida and Pasteurella hemolytica, 11, 321

10.2105/AJPH.60.6.1109

Klein NC, 1997, Pasteurella multocida pneumonia, Semin Respir Infect, 12, 54

10.2169/internalmedicine.44.754

Steiner FT, 1987, Psoas muscle abscess due to Pasteurella multocida, J Urol, 137, 487, 10.1016/S0022-5347(17)44081-X

Kimura R, 2004, Pasteurella multocida septicemia caused by close contact with a domestic cat, case report and literature review, 10, 250

Raffi F, 1987, Pasteurella multocida bacteremia, report of thirteen cases over twelve years and review of the literature, 19, 385

10.1128/AAC.35.11.2419

10.1002/lt.500060112

Singh N, 2004, Bacteremias in liver transplant recipients, shift toward gram-negative bacteria as predominant pathogens, 10, 844

Singh N., 1998, Infectious diseases in the liver transplant recipient, Semin Gastrointest Dis, 9, 136

10.1056/NEJM200103083441001

10.1056/NEJM200103083441009

10.1126/science.1071699

Vincent JL, 2005, Drotrecogin alfa (activated) treatment in severe sepsis from the global open‐label trial ENHANCE, further evidence for survival and safety and implications for early treatment, 33, 2266

10.1056/NEJMoa050935

10.1097/01.TP.0000054842.34916.E8

Pastores SM, 2002, Septic shock and multiple organ failure after hematopoietic stem cell transplantation, treatment with recombinant human activated protein C, 30, 131

Pastores SM, 2005, A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis, lessons in clinical research, 36, 721

10.1056/NEJM199806113382407

2004, Strategies for safe living following solid organ transplantation, Am J Transplant, 4, 156